180 related articles for article (PubMed ID: 32491248)
1. Amyloid-beta
Yeung JHY; Calvo-Flores Guzmán B; Palpagama TH; Ethiraj J; Zhai Y; Tate WP; Peppercorn K; Waldvogel HJ; Faull RLM; Kwakowsky A
J Neurochem; 2020 Oct; 155(1):62-80. PubMed ID: 32491248
[TBL] [Abstract][Full Text] [Related]
2. The Acute Effects of Amyloid-Beta
Yeung JHY; Palpagama TH; Tate WP; Peppercorn K; Waldvogel HJ; Faull RLM; Kwakowsky A
Front Neurosci; 2019; 13():1427. PubMed ID: 32009891
[TBL] [Abstract][Full Text] [Related]
3. Toward a dissection of β-Amyloid localized effects on glutamatergic hippocampal repertoire: An Editorial Highlight for "Amyloid-beta
Méndez JA; Ortega A
J Neurochem; 2020 Oct; 155(1):7-9. PubMed ID: 32681746
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex.
Yeung JHY; Walby JL; Palpagama TH; Turner C; Waldvogel HJ; Faull RLM; Kwakowsky A
Brain Pathol; 2021 Nov; 31(6):e13005. PubMed ID: 34269494
[TBL] [Abstract][Full Text] [Related]
5. Amyloid Fibril-Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses.
Wu J; Bie B; Foss JF; Naguib M
Mol Neurobiol; 2020 May; 57(5):2290-2300. PubMed ID: 32008166
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent changes in vesicular glutamate transporter 1 and 2 expression in the gerbil hippocampus.
Jung HY; Yoo DY; Park JH; Kim JW; Chung JY; Kim DW; Won MH; Yoon YS; Hwang IK
Mol Med Rep; 2018 May; 17(5):6465-6471. PubMed ID: 29532891
[TBL] [Abstract][Full Text] [Related]
8. Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain.
Zheng M; Liu J; Ruan Z; Tian S; Ma Y; Zhu J; Li G
Amyloid; 2013 Mar; 20(1):13-20. PubMed ID: 23286786
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
10. Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.
Procaccini C; Maksimovic M; Aitta-Aho T; Korpi ER; Linden AM
Neuroscience; 2013 Oct; 250():189-200. PubMed ID: 23867766
[TBL] [Abstract][Full Text] [Related]
11. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
Canas PM; Simões AP; Rodrigues RJ; Cunha RA
Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236
[TBL] [Abstract][Full Text] [Related]
12. Riluzole ameliorates soluble Aβ
Yang Y; Ji WG; Zhang YJ; Zhou LP; Chen H; Yang N; Zhu ZR
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110077. PubMed ID: 32818535
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1-40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.
Martins WC; dos Santos VV; dos Santos AA; Vandresen-Filho S; Dal-Cim TA; de Oliveira KA; Mendes-de-Aguiar CB; Farina M; Prediger RD; Viola GG; Tasca CI
Neurotox Res; 2015 Jul; 28(1):32-42. PubMed ID: 25827781
[TBL] [Abstract][Full Text] [Related]
14. The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (Aβ) species on long-term potentiation (LTP).
Rammes G; Seeser F; Mattusch K; Zhu K; Haas L; Kummer M; Heneka M; Herms J; Parsons CG
Neuropharmacology; 2018 Sep; 140():184-192. PubMed ID: 30016667
[TBL] [Abstract][Full Text] [Related]
15. Reversal of novelty-induced hippocampal c-Fos expression in GluA1 subunit-deficient mice by chronic treatment targeting glutamatergic transmission.
Maksimovic M; Aitta-aho T; Korpi ER
Eur J Pharmacol; 2014 Dec; 745():36-45. PubMed ID: 25446922
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta
Elibol B; Beker M; Terzioglu-Usak S; Dalli T; Kilic U
Phytomedicine; 2020 Dec; 79():153324. PubMed ID: 32920292
[TBL] [Abstract][Full Text] [Related]
17. Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation.
Kimura R; MacTavish D; Yang J; Westaway D; Jhamandas JH
Mol Neurobiol; 2017 Jan; 54(1):748-754. PubMed ID: 26768593
[TBL] [Abstract][Full Text] [Related]
18. Intrahippocampal amyloid-β (1-40) injections injure medial septal neurons in rats.
Colom LV; Castaneda MT; Hernandez S; Perry G; Jaime S; Touhami A
Curr Alzheimer Res; 2011 Dec; 8(8):832-40. PubMed ID: 22044024
[TBL] [Abstract][Full Text] [Related]
19. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC
Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332
[TBL] [Abstract][Full Text] [Related]
20. Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine Receptor.
Hascup KN; Hascup ER
J Alzheimers Dis; 2016 May; 53(1):337-47. PubMed ID: 27163813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
